drug_type
RELEVANT_DRUG
intervention_type
Antibody–drug conjugate
drug_description
Investigational antibody–drug conjugate that targets TROP-2 on TNBC cells and, after internalization, releases a topoisomerase I inhibitor payload to induce DNA damage.
nci_thesaurus_definition
NCI thesaurus definition not available.
drug_category
ANTIBODY DRUG CONJUGATE
drug_class
Conjugate
drug_delivery_route
Intravenous
drug_mechanism_of_action
Targets TROP-2 on TNBC cells; after antibody-mediated binding and internalization, releases a topoisomerase I inhibitor payload that induces DNA damage and tumor cell death.
drug_name
FDA018-ADC
nct_id_drug_ref
NCT06519370